Background and Purpose-Stroke is one of the leading causes of adult disability and death in developing countries.
arly diagnosis or prognosis of stroke is not straightforward. Although CT, MRI, and transcranial Doppler can be used for stroke diagnosis, they are costly, time-consuming, complex, and not universally available. Worse, small vessel occlusion (SVO), a subtype of cerebral infarctions that includes lacunar infarction, can be diagnosed with a normal CT/MRI examination only if a relevant brain stem or subcortical hemispheric lesion has a diameter of Ͻ1.5 cm and no potential cardiac sources of embolism exist. Moreover, no more than 50% greater stenosis of the large extracranial arteries and ipsilateral artery can occur, 1 so diagnosis via traditional methods is difficult. Thus, the study of plasma biomarkers for the diagnosis and prognosis of stroke has been the focus of extensive research. [2] [3] [4] [5] [6] However, at present, neither a biomarker nor a biomarker profile is generally accepted in clinical practice.
Additionally, stroke occurs because of a variety of complex factors, including cardiovascular disease and diabetes. For this reason, a new approach, such as "omics" technology for stroke, is required. In particular, metabolomics, an emerging field of omics technologies, can investigate the perturbed metabolic pattern in a complete set of metabolites in body fluids or tissue for early diagnosis and therapy monitoring and can clarify the pathogenesis of many diseases. 7 To date, however, no metabolomics study for stroke has been reported. In this study, we investigated the perturbed metabolic pattern in plasma and urine from patients with cerebral infarction and identified metabolic markers associated with stroke using nuclear magnetic resonance (NMR) spectroscopy coupled with multivariate statistical analysis.
Subjects and Methods

Study Subjects
Stroke patients with SVO 1 by the TOAST classification and healthy volunteers were recruited from Daejeon Korean Oriental Hospital and Wonkwang Korean Oriental Hospital. Samples in this study were collected from patients with sudden onset of neurological symptoms who were admitted for a suspected ischemic event within 72 hours of onset.
The healthy individuals were free of medically manifest disease. Individuals with a stroke history or showing any sign of stroke, based on CT/MRI evaluation, such as TIA or silent infarction, were excluded from the healthy control group to reduce the confounding effects of additional risk factors; individuals with diabetes mellitus or other serious vascular diseases were also excluded from both patient and healthy control groups (information of subjects is in Supplemental Tables I and II , http://stroke.ahajornals.org).
Informed consent was obtained from all participants. The study protocol was approved by the Institutional Review Board of the Korea Institute of Oriental Medicine and the 2 medical centers that recruited the participants.
Sample Preparation and 1 H-NMR Spectroscopy
Venous blood and urine were collected from overnight-fasted participants for standardized conditions. For the plasma experiment, 200 L of plasma was mixed with 450 L of saline solution (10% D 2 O for locking signal, 0.9% NaN 3 ). Then, 600-L aliquots of the supernatant were transferred into 5-mm NMR tubes for analysis. For the urine, 400-L aliquots of supernatant were mixed with 230 L of sodium phosphate buffer (0.2 mol/L, pH 7.0, 0.018% NaN 3 dissolved) and adjusted to pH 7.0Ϯ0.1. Then, 540 L of urine and 60 L of D 2 O (5 mmol/L DSS dissolved) were transferred to 5-mm NMR tubes for analysis. 1 H-NMR spectra of plasma and urine were acquired on a VNMRS-600MHz NMR spectrometer (Varian) at 25°C using a triple-resonance 5-mm HCN salt-tolerant cold probe. Details about NMR sequences and data handling of plasma and urine are in the Supplemental information (http://stroke.ahajornals.org).
Data Processing of the NMR Spectra and Multivariate Statistical Analysis
Each 1 H-NMR spectrum from plasma and urine was segmented into equal width (0.005 ppm for plasma and 0.003 ppm for urine) corresponding to regions 0.75 to 8.6 ppm and 0.8 to 8.6 ppm, respectively. Spectral data were normalized to the total spectral area. Data files were imported into MATLAB (R2008a; Mathworks) and all spectra were aligned using the correlation-optimized warping method. 8 The resulting data sets were then imported into SIMCA-P version 12.0 (Umetrics), and all data were then Pareto-scaled 9 for multivariate statistical analysis. First, principal components analysis (PCA), an unsupervised pattern recognition method, was performed. Next, an orthogonal partial least-squares discriminant analysis (OPLS-DA) was used to maximize covariance between the measured data (peak intensities in NMR spectra) and the response variable (predictive classifications).
Analysis of NMR spectral data was accomplished using targeted profiling through the use of Chenomx NMR Suite 6.0 (Chenomx). OPLS-DA was applied to the concentration data of assigned metabolites. The regression coefficients plot was then used, which shows all metabolites that contribute to the separation between the studied groups.
Statistical Analysis and Validation
A 2-sided t test, Mann-Whitney U test (non-Gaussian distribution) for concentrations of metabolites, and Fisher exact tests for categorical data were performed using GraphPad Prism (version 5 for Windows; GraphPad Software). The default method of 7-fold internal cross-validation of SIMCA-P software was applied. External validations with acute phase stroke patients (within 24 hours from onset) with 80% of the data as the training set and the remaining 20% as the prediction set were performed. Detail about multivariate analysis and validation are in the Supplemental information. Figure 1 shows representative 1-dimensional 1 H-NMR spectra of plasma and urine from healthy individuals and stroke patients. Spectra of plasma and urine were dominated by numerous metabolites, as shown by the metabolite key in Figure 1 . Initially, principal components analysis was applied to examine the intrinsic variation in the plasma and urine data set. The score plots (Supplemental Figure I , http://stroke.ahajornals.org) showed slight separations between the 2 groups from plasma (R 2 Xϭ0.757; Q 2 ϭ0.514) and urine (R 2 Xϭ0.613; Q 2 ϭ0.245) models. Next, OPLS-DA was performed to minimize the possible contribution of intergroup variability and to further improve the separation between the 2 groups. The score plots ( Figure  2A , B) from OPLS-DA models for plasma (R 2 Yϭ0.914; Q 2 ϭ0.778) and urine (R 2 Yϭ0.928;, Q 2 ϭ0.627) show a clear differentiation between healthy individuals and stroke patients. The model parameters for the explained variation, R 2 , and the predictive capability, Q 2 , were significantly high (R 2 , Q 2 Ͼ 0.5) in plasma and urine, indicating excellent models. OPLS-DA loading and S-plots were generated to identify the metabolites responsible for the differentiation in the score plots (Figure 2C , D; S-plots not shown). Plasma of the stroke patients were characterized by higher levels of lactate, alanine, lipid CH 2 CH 2 CO, pyruvate, glycolate, and formate, and lower levels of very-low-density lipoprotein/low-density lipoprotein CH 3 , leucine, isoleucine, valine, very-low-density lipoprotein/low-density lipoprotein (CH 2 ) n , lipid CH 2 CH 2 CϭC, glutamine, methanol, 4-hydroxyphenylacetate, and -methylhistidine compared to those of the healthy individuals. In OPLS-DA loading plots, urine of stroke patients was characterized by decreased levels of citrate, dimethylamine, creatinine, taurine, glycine, and hippurate, and by increased levels of O-acetylcarnitine, trimethylamine-N-oxide, betaine, and carnitine.
Results
Metabolomics Analysis of Plasma and Urine From Healthy Individuals and Stroke Patients
To further investigate the significance of these metabolites, a combination of statistical approaches was necessary. 10 Thus, we selected biomarkers using the t test, as well as jack-knifing of coefficients, and variable importance of projection values.
Among the higher levels of metabolites in the plasma of stroke patients compared with healthy individuals, lactate, glycolate, pyruvate, and formate showed statistically significant differences between the 2 groups. Among the lower levels of metabolites in stroke patients, very-low-density lipoprotein/low-density lipoprotein CH 3 , valine, lipid CH 2 CH 2 CϭC, methanol, and glutamine showed statistically significant differences. In urinary metabolites, only citrate, dimethylamine, creatinine, glycine, and hippurate showed statistically significant differences (Table 1) .
Additionally, OPLS-DA was applied to the targeted profile that we observed on the OPLS-DA loading plot. Based on the results of the OPLS-DA regression coefficients from plasma, stroke patients primarily excreted higher levels (variable importance of projection Ͼ1) of glycolate, formate, pyruvate, and lactate, whereas healthy individuals primarily excreted higher levels of methanol, glutamine, and lipid CH 2 CH 2 CϭC. Stroke patients excreted lower levels (variable importance of projection Ͼ1) of citrate, creatinine, glycine, hippurate, and dimethylamine in urine (Supplemental Figure I) .
Homocysteine Concentration
To confirm the stroke pathway related with observed metabolites, homocysteine concentrations in urine model subjects were measured ( Table 2 ). The geometric mean value of the total homocysteine was 2.05 mol/L higher in stroke patients. Generally, the normal plasma concentration of total homocysteine concentrations after adjustment for gender and age is estimated to be up to 10 mol/L. 11 In our study, the proportion of patients with Ͼ10.0 mol/L homocysteine was Ϸ2-fold higher than in control subjects.
Prediction of Class Membership
External validation was performed to test the reliability of the OPLS-DA model. In the plasma model, the corresponding training and prediction sets were randomly selected, and validation was repeated 3 times with equally numbered sets of different samples. The range for R 2 was 0.885 to 0.915, and Q 2 ranged from 0.723 to 0.738. The average classification rate was 96% for healthy subjects (9.6 of 10) and 100% for stroke patients (10 of 10; Figure 3A ). In addition, acute phase patients (within 24 hours from onset and no overnight fasting) also had correctly predicted classes (16 of 16; Figure 3B ). Furthermore, a false-negative diffusion-weighted imaging study result is not uncommon during the first 24 hours of ischemic stroke; 12 therefore, the plasma of 4 false-negative diffusion-weighted imaging results were collected within 24 hours of onset, and 3 of 4 were correctly classified (data not shown).
Discussion
Among 3000 SVO patients investigated in our study, 29.1% and 4.1% of SVO patients had diabetes and vascular disease, respectively. Therefore, Ϸ30% SVO patients with diabetes or cardiovascular disease might not fit the metabolic profiles suggested in this study, because patients with diabetes and vascular diseases were excluded from our study.
Nevertheless, potential biomarkers, such as glycolate, formate, pyruvate, lactate, methanol, glutamine, lipid CH 2 CH 2 CϭC, creatinine, glycine, hippurate, and dimethylamine, observed from this study can explain the pathogenesis of stroke in a systemic review.
Among these metabolites, Graham et al 2 suggested that lactate arises from a shift toward anaerobic glycolysis in potentially viable cells that continue to metabolize glucose under local hypoxic conditions. Alternatively, it may be inflammatory and phagocytic cell infiltration in the brain parenchyma after a stroke. Additionally, we observed significantly elevated levels of lactate and pyruvate from plasma, and decreased levels of citrate from urine. These are metabolites associated with energy metabolism, especially anaerobic glycolysis. Because limited oxygen exists after infarction, lactate and pyruvate increase from anaerobic glycolysis of serum glucose. Furthermore, because little pyruvate can enter the Krebs cycle under these conditions, citrate also decreases ( Figure 4A ).
We observed increased levels of formate and glycolate, and decreased levels of dimethylamine, glycine, hippurate, and methanol in stroke patients. These are strongly related to folic acid deficiency and hyperhomocysteinemia, which has been suggested to be an independent risk factor for stroke 5, 6 ( Figure 4B ).
As one of the folic acid activities, formate is oxidized via the folate pathway by combining with tetrahydrofolate through the mediation of formyltetrahydrofolate synthetase to form 10-formyl-tetrahydrofolate. Glycine is biosynthesized in the body from the amino acid serine via tetrahydrofolate. Thus, folic acid deficiency is related to increased formate and decreased glycine. Furthermore, these elevated formate levels may accelerate metabolic acidosis after stroke. 13 Additionally, glycolate is formed from glyoxylate, which is a product of glycine catabolism. Therefore, as glycine decreases, glycolate increases. Moreover, it results in lower concentrations of hippurate, which is synthesized via glycine conjugation with benzoate in the liver. 14 Among the effects of folic acid deficiency, hyperhomocysteinemia has been suggested as a major risk factor of stroke. 5, 6 Elevated total homocysteine induces oxidative injury to vascular endothelial cells and impairs the production of nitric oxide, a strong vascular relaxing factor, in the endothelium. 15, 16 Hyperhomocysteinemia also enhances platelet adhesion to endothelial cells and promotes the growth of vascular smooth muscle cells. 16, 17 Moreover, Iso et al 18 reported that ischemic stroke, especially lacunar infarction (SVO type) had a greater association with homocysteine than did large-artery occlusion stroke or hemorrhagic stroke. These results are consistent with our data, which characterized an SVO subtype of ischemic stroke. Y-predicted scatter plot of orthogonal partial least-squares discriminant analysis (OPLS-DA) models validated with 80% (44 stroke, 37 healthy) of the data as the training set and the remaining 20% (10 stroke (᭜ case) and 10 healthy (᭜ cont) as the prediction set (A), and external validation using plasma of acute phase patients (᭜) (B). All cases and controls were correctly classified, and acute phase patients (within 24 hours of onset and no overnight fasting) were also correclty predicted. Red, stroke patients; green, healthy individuals; predicted Y cutoff of 0.5.
Synthesis of methanol in the body is attributable to S-adenosylmethionine. 19, 20 Thus, decreased methanol after cerebral infarction also may be related to hyperhomocysteinemia, which would cause a lack of methionine and S-adenosylmethionine.
Also, accumulated asymmetrical dimethylarginine, which is an endogenous inhibitor of nitric oxide synthase, has been proposed to be an important mediator of vascular dysfunction during hyperhomocysteinemia. 21 Because hyperhomocysteinemia impairs dimethylarginine dimethylaminohydrolase activity, which inhibits accumulated asymmetrical dimethylarginine conversion to L-citrulline and dimethylamine, 22 the level of dimethylamine decreases.
Recently, glial fibrillary acidic protein was found to be a sensitive marker of brain damage in patients with smaller lacunar lesions or minor strokes. 23 Pekny et al 24 also demonstrated that the genetic removal of glial fibrillary acidic protein is associated with an increase in intracellular glutamine concentration. Thus, postischemic upregulation of glial fibrillary acidic protein expression may be correlated with decreased glutamine concentrations.
We performed a 1 H-NMR-based metabolomic approach in patients with cerebral infarction to identify potential biomarkers of stroke. Using OPLS-DA analysis, we detected a clear separation in the metabolic profiling, and metabolic pathways of cerebral infarction were characterized by anaerobic glycolysis, folic acid deficiency, and hyperhomocysteinemia.
Conclusions
In conclusion, this study suggested that the noninvasive approach of metabolic profiling with NMR spectroscopy can be used not only as a novel diagnostic technique but also as a tool for understanding pathogenesis of cerebral infarction. 
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NMR sequences and data handling for urine and plasma.
Difference between urine and plasma is protein-depleted or not. For protein-depleted samples such like urine, feces, and (protein-depleted) cell lines, "NOESYPRESAT(RD-90°-t1-90°-tm-90°-FID acquisition)" pulse sequence are commonly used for presaturation of the water resonance. However, Spectra from plasma samples acquired with the Noesypresat pulse sequence typically result in spectra containing rolling baselines due to broad, unresolved, signals from proteins, hence, the plasma samples were also analyzed using the Carr-PurcellMeiboom-Gill (CPMG) spin-echo pulse sequence (RD-90°-(τ-180°-τ) n-ACQ) with a total T2 relaxation time of 60. The CPMG-pulse sequence allows the 'spectral editing/filtering' of the broad protein signals and produces spectra with flat baselines 1 . In addition, the commonly used internal chemical-shift reference (0ppm) compound such as TSP or DSS has also been used as a concentration standard in bio-fluid containing few macromolecular components (e.g., urine, cerebrospinal fluid). However, it cannot be used as a concentration standard in plasma because it is adsorbed to the proteins and broadens their own signal, and the apparent intensity of the signal reduces. The degree of adsorption depends on the overlaid composition of their macromolecules, which varies in each subject 2 Therefore, we use the concentrations for urine while normalized relative intensities of different metabolites were used for plasma.
Multivaliate Analysis 5 1) OPLS-DA
Orthogonal projections to latent structure-discriminant analysis (OPLS-DA), is a type of supervised classification and regression method that correlates spectroscopic data to a certain property, such as class membership, in this case, stroke patient or healthy subject. It is a modification of PLS, which separates the systematic variation in X (NMR data) into two parts, one that is linearly related to Y (class membership) and one that is orthogonal to Y. Hence, the OPLS model comprises two components of modeled variation as described in Equation (1), where T p denotes the predictive score matrix for X, P p denotes the predictive loading matrix for X, T o denotes the corresponding Y-orthogonal score matrix, P o denotes the loading matrix of Y-orthogonal components and E denotes the residual matrix of X.
Y-predictive (
) component, which represents the between class variation, and (2) the Y-orthogonal ( ) component also referred to as the uncorrelated variation, which constitutes the within class variation 3 . Classification by the estimated OPLS-DA model is accomplished in two steps. First, the Y-orthogonal variation is removed from the data matrix X as shown in Equation (2) Second, Y hat is estimated using the updated X p and the predictive components from the OPLS-DA model, which are estimated from the training data set 4 .
2) Score and Loading plots
By using OPLS-DA a data table X is modeled as , and X p = were used for estimation of Y hat. In the expression, T and P are score and loading matrix, respectively. The scores are the co-ordinates of the observation in the model plane. Alternatively, these scores may be seen a new variables which summarize the old ones. And the meaning of the score is given by the loadings. The loadings define the orientation of the model plane with respect to the original X-variables. Algebraically, loading inform how the variables are linearly combined to form the scores. The loading unravel the magnitude (large of small correlation) and the manner (positive and negative correlation) in which the measured variables contribute to the scores. In here, loading plots (w*c plot) showed both the X-weights (w; influence of the individual X-variables in the model) and Y-weights(c; influence of the two Y-variables in the model), and thereby the correlation structure between X and U. One sees how the X and Y variables combine in the projections, and how the X variables relate to Y 5 .
3) VIP (variable importance in the projection)
In a PLS model, variable importance in the projection (VIP) is a parameter that shows the importance of a variable. VIP is the sum over all model dimensions of the contributions of variable influence (VIN) for a given PLS dimension (a) and a given X term (k); VIN 2 is computed from the squared PLS weight of that X term, multiplied by the percent-explained the sum of squares (SS) by that PLS dimension. VIP value is calculated from the accumulated value over all PLS dimensions, divided by the total percent-explained SS by the PLS model and multiplied by the number of terms in the model.
Thus, terms with large values of VIP are the most relevant for explaining dependent variable. The parameters that are found to be the most important are the ones presenting a VIP value larger than 1. Loading scores describe the correlation between the original variables and the new component variables, whereas VIP parameters are essentially a measure of the degree to which a particular variable explains the Y variance (class membership).
4) Coefficients
The PLS model parameters are used to re-express the Y variables as multiple regression models of the X variables: Y=XB X refers to the X matrix, including squared and/or cross terms if those were added and Y is the matrix of responses, and B became the vector of regression coefficients. The values of the regression coefficients depend on the scaling of X and Y.
In this study, we showed the centered and scaled coefficients (CoeffCS), which the coefficients when X is scaled and centered and Y is scaled. These coefficients are used for interpreting the influence of the variables X on Y. The centered and scaled coefficients are expressed according to the following formula: = Scaling weight of The coefficient plot summarizes the relationship between the Y variables and the X variables, whereas the VIP values show the overall contribution of each X-variable to the PLS models. The major difference is that the VIP plot describes which X variables characterize the X block well and which variables correlate with Y, therefore in extreme cases, it is possible for an X variable to have a high VIP but not be related to Y at all. Thus, we chose a biomarker using the coefficient and VIP value. th of the data until all the data have been predicted. The predicted data are then compared with the original data and the sum of the squared errors calculated for the whole dataset. This is then called the Predicted Residual Sum of Square (PRESS), which is compared with the residual sum of squares (RSS) of the previous dimension. In SIMCA-P+, CV is conducted for each consecutive model dimension starting with A=0. For each additional dimension, CV gives a PRESS. When PRESS is not significantly smaller than RSS, the tested dimension is considered insignificant and the model building is stopped. Then, RSS is divided by the initial sum of squares and subtracted from 1 and it calls a R 2 which provides an indication of how much of the variation within a data set can be explained by the various components of the model. In addition, the better the predictability of the model the lower PRESS will be. For convenience, PRESS was converted into Q 2 to resemble the scale of the R 2 . PRESS is divided by the initial sum of squares and subtracted from 1. Good predictions will have low PRESS and so high Q 2 .
2) External data validation.
Because cross validation cannot detect sampling bias, particularly in small sample sets, additional EV on samples was performed. In external validation, a portion of the training set, named as prediction set, that was not used when the model was built, is left out of the model and then predicted. In addition, Partial least-squares to latent structures, PLS, is a regression method commonly used in multivariate studies in order to find the relationship between two data tables referred to as X, here the NMR data, and Y, here a binary vector with the value 0 for healthy subject and 1 for stroke patients. For the two-class case such like our case, unless the classes are inhomogeneous or greatly differing in size, straightforward 0.5 threshold has frequently been employed to determine class belonging 6 . For the first validation test (Figure 3A ), the examination with MRI test was used as a diagnostic tool for patients with sudden onset of neurologic symptoms who are admitted for a suspected ischemic event within 24 hours of onset, and 16 stroke patients were validated. For the second test ( Figure 3B ), 81 samples (44 stroke/ 37 healthy) from the data set defined the training set and 20 samples (10 stroke/10 healthy) served as the prediction set, and validation was repeated three times with equally numbered sets of different samples.
